Forum Replies Created

  • Sylvia Kusemererwa

    Member
    August 10, 2020 at 7:29 pm

    That would be interesting to observe! However, if provided as part of the study design, women would choose between taking a pill and using a ring. Similar to what is being done under the REACH trial, 6 months on pills and 6 months on the ring followed by a crossover.

  • Sylvia Kusemererwa

    Member
    July 28, 2020 at 5:17 pm

    The distinction between some of the GPP concepts is quite challenging because of the overlap. Follow up discussion would be helpful. Thanks

  • Sylvia Kusemererwa

    Member
    July 22, 2020 at 2:45 pm

    Hi Daisy,

    Is there a way to get this information now that the date is past?

    Sylvia

  • Sylvia Kusemererwa

    Member
    August 5, 2020 at 8:04 pm

    They usually need more than one efficacy trial to licence a drug.

    However considering the different populations, CAB LA could be licensed for MSM and trans women, then the label updated to include cis women when the results become available.